Myelodysplastic Syndrome (MDS) Treatment Market Expands with Advancements in Targeted Therapies & Hematopoietic Stem Cell Research
[Hyderabad, March 26th, 2025] – The Myelodysplastic Syndrome (MDS) Treatment Market is experiencing significant growth, driven by an increase in bone marrow disorders, advancements in immunotherapy, and a rise in clinical trials for new hematologic treatments. Valued at USD XX billion in 2023, the market is projected to grow at a CAGR of XX% from 2024 to 2031, reaching USD XX billion by...